Cleared Traditional

K151613 - iLab Polaris Multi-Modality Guidance System

K151613 is an FDA 510(k) clearance for iLab Polaris Multi-Modality Guidance System, manufactured by Boston Scientific Corporation. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 113-day FDA review.

K151613 · Boston Scientific Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2015
Decision
113d
Days
Class 2
Risk

K151613 is an FDA 510(k) clearance for the iLab Polaris Multi-Modality Guidance System. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Boston Scientific Corporation (Maple Grove, US). The FDA issued a Cleared decision on October 6, 2015 after a review of 113 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Boston Scientific Corporation devices

FDA 510(k) Submission Details - K151613

510(k) Number K151613 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 15, 2015
Decision Date October 06, 2015
Days to Decision 113 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d faster than avg
Panel avg: 125d · This submission: 113d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 365
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K151613.
Holter System
K151787 · Edan Instruments, Inc. · Jan 2016
MUSE Cardiology Information System
K152993 · Ge Medical Systems Information Technologies, Inc. · Jan 2016
WorkMate Claris System, WorkMate Claris System Display Plus
K151911 · St Jude Medical · Oct 2015
TM eCloud ECG Analysis System
K142349 · Telemed Solutions, Inc. · Sep 2015
Rhythm View Workstation (non-streaming, steaming option)
K151245 · Topera, Inc. · Sep 2015
ECVUE Mapping System
K150990 · Cardioinsight Technologies, Inc. · Jul 2015